Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Hepatitis B Vaccine in national immunization schedule: a preventive step in India.

Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M.

Hum Vaccin. 2011 Dec;7(12):1387-8. doi: 10.4161/hv.7.12.17878. Epub 2011 Dec 1.

PMID:
22134433
2.

Immunization recommendations expanded for hepatitis B, HPV, pertussis vaccines.

Kuehn BM.

JAMA. 2012 Apr 4;307(13):1353-4. doi: 10.1001/jama.2012.367. No abstract available.

PMID:
22474190
3.

Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1709-11.

5.

Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine delivery.

Hendrickx G, Vorsters A, Van Damme P.

Curr Opin Infect Dis. 2012 Oct;25(5):578-83. doi: 10.1097/QCO.0b013e328357e65c. Review.

PMID:
22907280
6.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2007 Oct 26;56(42):1114.

7.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.

Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Feb 17;55(6):158-9. MMWR Morb Mortal Wkly Rep. 2007 Dec 7;56(48):1267.

8.

Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan.

Su WJ, Liu CC, Liu DP, Chen SF, Huang JJ, Chan TC, Chang MH.

J Infect Dis. 2012 Mar 1;205(5):757-62. doi: 10.1093/infdis/jir852. Epub 2012 Jan 19.

PMID:
22262790
9.

DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.

Yin Y, Wu C, Song J, Wang J, Zhang E, Liu H, Yang D, Chen X, Lu M, Xu Y.

PLoS One. 2011;6(7):e22524. doi: 10.1371/journal.pone.0022524. Epub 2011 Jul 22.

10.

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.

Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH.

Pediatrics. 1999 Feb;103(2):E14.

PMID:
9925860
11.
12.

Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.

McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, Homan C, Parkinson AJ.

Hepatology. 2011 Sep 2;54(3):801-7. doi: 10.1002/hep.24442. Epub 2011 Jul 19.

PMID:
21618565
13.

Benefits of early hepatitis B immunization programs for newborns and infants.

Van Herck K, Van Damme P.

Pediatr Infect Dis J. 2008 Oct;27(10):861-9. doi: 10.1097/INF.0b013e318173966f.

PMID:
18776823
14.

Production of hepatitis B surface antigen in transgenic plants for oral immunization.

Richter LJ, Thanavala Y, Arntzen CJ, Mason HS.

Nat Biotechnol. 2000 Nov;18(11):1167-71.

PMID:
11062435
15.

Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization.

Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, Paupunwatana S, Chaiear K, Khwanjaipanich S, Poovorawan Y.

Trop Med Int Health. 2006 Oct;11(10):1496-502.

16.

Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran.

Yahyapour Y, Karimi M, Molaei HR, Khoddami E, Mahmoudi M.

Oman Med J. 2011 Nov;26(6):399-403. doi: 10.5001/omj.2011.103.

17.

Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children.

Aypak C, Yüce A, Yıkılkan H, Görpelioğlu S.

Eur J Pediatr. 2012 Dec;171(12):1761-6. doi: 10.1007/s00431-012-1815-4. Epub 2012 Aug 16.

PMID:
22895894
18.

[Immunization efficacy and tolerance of a tetravalent vaccine against diphtheria, tetanus, pertussis (acellular) and hepatitis B].

Giammanco G, Pignato S, Taormina S, Genovese M, Maggio M, Giammanco A, Anfuso S, Pittalà D, Li Volti S, Soncini R.

Ann Ig. 1997 May-Jun;9(3):209-13. Italian. No abstract available.

PMID:
9312244
19.

Prevalence of hepatitis B virus infection in a highly endemic area of southern China after catch-up immunization.

Fang ZL, Harrison TJ, Yang JY, Chen QY, Wang XY, Mo JJ.

J Med Virol. 2012 Jun;84(6):878-84. doi: 10.1002/jmv.23278.

PMID:
22499009
20.

Childhood hepatitis B virus infections in the United States before hepatitis B immunization.

Armstrong GL, Mast EE, Wojczynski M, Margolis HS.

Pediatrics. 2001 Nov;108(5):1123-8.

PMID:
11694691

Supplemental Content

Support Center